Stimit
Cambridge, US · Founded 2016 · Delaware corporation · 1 known investors
Find your way into Stimit
Founders & leadership
GG
Gary GoldbergNamed on SEC filing
MG
Michael GoldbergNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$52.6M disclosed across 2 rounds · 2020–2023
▶$32MraisedJun 2023 · 22 investors · BiotechnologyRule 506(b)
▶$32MraisedJun 2023 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gary GoldbergDirector
- Michael S. GoldbergExecutive Officer, Director
- Jason ColomaDirector
- Chuck CarignanExecutive Officer
- Antonio GualbertoExecutive Officer
- Kouki HarasakiDirector
- Ali FarahanchiDirector
- Offering amount
- $50M
- Amount sold
- $32M
- Proceeds to insiders
- $4.4M
- First sale
- May 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20.6MraisedDec 2020 · 5 investors · BiotechnologyRule 506(b)
▶$20.6MraisedDec 2020 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gary GoldbergExecutive Officer, Director
- Michael GoldbergExecutive Officer, Director
- Offering amount
- $29.6M
- Amount sold
- $20.6M
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Stimit's investors?
- Stimit's investors include Camford Capital.
- How much funding has Stimit raised?
- Stimit has disclosed $52.6M raised across 2 rounds.
- Where is Stimit headquartered?
- Stimit is headquartered in Cambridge, US.